ArticleJournal of nanobiotechnology2019

Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.

Yang Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.